NPS Pharma Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Bedminster NJ United States (1986)
Status: Acquired by Shire (2015) → now Takeda (2018)

Organization Overview

First Clinical Trial
2001
NCT00172133
First Marketed Drug
2012
teduglutide (gattex kit)
First NDA Approval
2012
teduglutide (gattex kit)
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

NPS PHARMS INC